CNS(Vafidemstat) Appointed renowned Rolando Gutierrez-Esteinou, M.D. as new CMO for CNSPreparing protocol resubmission to incorporate FDA guidance on Phase III PORTICO-2 trial in aggression in BPDOngo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results